Heron Therapeutics
HRTX
#10090
Rank
โ‚น6.60 B
Marketcap
โ‚น34.81
Share price
26.48%
Change (1 day)
-64.63%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2023 (TTM): -โ‚น95.90

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น17.84. In 2022 the company made an earnings per share (EPS) of -โ‚น162.48 an increase over its 2021 EPS that were of -โ‚น211.32.

EPS history for Heron Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น95.90-40.98%
2022-โ‚น162.48-23.11%
2021-โ‚น211.32-10%
2020-โ‚น234.79-0%
2019-โ‚น234.791.21%
2018-โ‚น231.98-32.7%
2017-โ‚น344.68-19.34%
2016-โ‚น427.3354.76%
2015-โ‚น276.121.73%
2014-โ‚น271.42-16.23%
2013-โ‚น324.0291.67%
2012-โ‚น169.05-31.45%
2011-โ‚น246.63-27.06%
2010-โ‚น338.10-43.75%
2009-โ‚น601.08-57.33%
2008-โ‚น1,409-82.92%
2007-โ‚น8,24620.61%
2006-โ‚น6,837175.76%
2005-โ‚น2,479-21.43%
2004-โ‚น3,156100%
2003-โ‚น1,578-38.24%
2002-โ‚น2,555161.54%
2001-โ‚น976.75-106.46%
2000โ‚น15,1112051.55%
1999โ‚น702.33839.73%
1998โ‚น74.74-105.48%
1997-โ‚น1,365-88.16%
1996-โ‚น11,528

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
SurModics
SRDX
-โ‚น115.52 547.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pacira Biosciences
PCRX
โ‚น32.87-284.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น940.12-5,368.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
โ‚น37.57-310.53%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Nektar Therapeutics
NKTR
-โ‚น278.00 1,457.89%๐Ÿ‡บ๐Ÿ‡ธ USA